During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, ...

The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable ...

The agency has given a thumbs up to Sanofi’s Merilog (insulin-aspart-szjj) as the first biosimilar to Novo Nordisk’s NovoLog for patients ... 38 million in the U.S. with diabetes, 8.4 million ...

President Trump announced an investment from Taiwan Semiconductor Manufacturing Co. of $100 billion in chip-manufacturing plants in the U.S. Photo: Samuel Corum/Bloomberg News WASHINGTON—Taiwan ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. “Merilog ...

(RTTNews) - The U.S. Food and Drug Administration announced ... Merilog has been approved as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

It calls the new drug “Merilog,” a biosimilar to the widely-used insulin product Novolog (insulin aspart). READ: Stem cells show promise in reversing type 1 diabetes The FDA defines a ...